TORNTPHARM · Concall Summary
TORRENT PHARMACEUTICALS L
The document is a communication from Torrent Pharmaceuticals Limited regarding the transcript of a discussion with analysts and investors about the financial results for the quarter ended 30th June 2026. It references a previous letter dated 17th July 2026 and states that the transcript has been made available on the company's website. The communication is signed by Chintan M. Trivedi, the Company Secretary, and includes details for the BSE and NSE listing codes. The document serves to inform stakeholders about the availability of the financial results discussion transcript.
The document provided factual information regarding the availability of the transcript.
View source filing →Earlier concalls
- 2026-05-27 — The document is a communication from Torrent Pharmaceuticals Limited to the stock exchanges regarding the transcript of …
- 2026-05-22 — The investor presentation reported on the audited financial results for Torrent Pharmaceuticals Limited for the quarter …
- 2026-02-20 — The document is a communication from Torrent Pharmaceuticals Limited regarding the transcript of a conference call with …
See TORNTPHARM's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free